| abstract |
Described herein are compounds selective for the 5-HT1D-like receptor, which have general formula (I) wherein: R1 is linear or branched loweralkyl; R2 is selected from a group of Formula (II, III, IV and V); R3 is selected from H and loweralkyl; R4 is selected from H and loweralkyl; one of R?5 and R6¿ is H and the other is independently selected form H, loweralkoxy, loweralkyl and hydroxy; and n is 1-3; or a salt, solvate or hydrate thereof. Also described is the use of these compounds as pharmaceuticals to treat indications where stimulation of the 5-HT¿1D?-like receptor is implicated, such as migraine. |